Tinea corporis and tinea cruris incidence, risk factors, and treatments in a cohort of 6.8 million patients with Medicaid, United States.

Sajewski ET, Benedict K, Caplan AS, Lipner SR, Gold JAW

Open source

DOI
10.1093/mmy/myaf117
Published
2026 Jan 2
Container
Medical mycology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/mmy/myaf117,
  title = {Tinea corporis and tinea cruris incidence, risk factors, and treatments in a cohort of 6.8 million patients with Medicaid, United States.},
  author = {Sajewski ET and Benedict K and Caplan AS and Lipner SR and Gold JAW},
  year = {2026},
  journal = {Medical mycology},
  doi = {10.1093/mmy/myaf117},
  url = {https://doi.org/10.1093/mmy/myaf117}
}

RIS

TY  - JOUR
TI  - Tinea corporis and tinea cruris incidence, risk factors, and treatments in a cohort of 6.8 million patients with Medicaid, United States.
AU  - Sajewski ET
AU  - Benedict K
AU  - Caplan AS
AU  - Lipner SR
AU  - Gold JAW
PY  - 2026
JO  - Medical mycology
DO  - 10.1093/mmy/myaf117
UR  - https://doi.org/10.1093/mmy/myaf117
ER  - 

APA

ET, S., K, B., AS, C., SR, L., & JAW, G. (2026). Tinea corporis and tinea cruris incidence, risk factors, and treatments in a cohort of 6.8 million patients with Medicaid, United States.. Medical mycology. https://doi.org/10.1093/mmy/myaf117

Source records